Importantly, Gpr132 deletion abolishes the cancer regulation by macrophage PPARγ or rosiglitazone, indicating that Gpr132 is an essential mediator of PPARγ functions in macrophages and tumor progression. The gene discussed is PPARG; the disease is neoplasm.